To Investigate the Effect of Montelukast on Behavior Problems in Children With Asthma

Phase 4 Study of to Investigation the Effect of Montelukast on Behavior Problems in Children With Asthma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01818635

Enrollment

600

Registered

2013-03-26

Start date

2013-03-31

Completion date

2015-01-31

Last updated

2015-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Behavior Problem, Montelukast

Brief summary

The purpose of the study to investigate whether montelukast lead to behavior problems in children with asthma.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Months to 60 Months

Healthy volunteers

Yes

Inclusion criteria

* To have asthmatic children aged 18-60 months * To have that receive prophylactic treatment for asthma * Healthy children will be enrolled among those being brought for routine controls

Exclusion criteria

* Children with other chronic disease * Children with chronic drug use (except for the treatment of asthma)

Design outcomes

Primary

Measure	Time frame	Description
To investigate the effect of montelukast on behavior problems in children with asthma	8 months	Montelukast frequently used in the treatment of asthmatic children. However, we believe that montelukast lead to behavior problems. In this study, we aimed to investigate that intake of montelukast whether lead to behavior problems.

Secondary

Measure	Time frame	Description
To compare the effects of inhaled corticosteroids and montelukast on the behavior problems.	8 months	In this study, it will be compared the effect on behavior changes between intake of inhaled steroid and montelukast.

Countries

Turkey (Türkiye)

Outcome results